Breaking

Post Top Ad

Your Ad Spot

Thursday, May 17, 2018

FDA Names Drugmakers In Delaying Scandal


Thursday, the Food and Drug Administration named drugmakers, including Celgene Corp., Johnson & Johnson, Gilead Sciences, and Novartis AG, as companies that are potentially blocking access to samples of their drugs to delay generic competition. Generic drugmakers may not be able to develop alternatives without access to samples of branded products. FDA Commissioner Scott Gottlieb said in a statement “I want to be very clear: a path to securing samples of brand drugs for the purpose of generic drug development should always be available,” The list of the dozens of pharmaceutical companies potentially blocking medical advancements can be found on the FDA’s website. https://ift.tt/2IwoVWT http://www.wochit.com This video was produced by YT Wochit News using http://wochit.com

No comments:

Post a Comment

Post Top Ad

Your Ad Spot

Pages